Replies to post #1341 on IDM Pharma, Inc. (IDMI)

[bowonwing]

<<I would think that the probability of non-approval was built into her estimate though.>> I disagree. I think her $11 p.t. was dependent upon FDA approval.

And remember when Bassett was following IDM, she stated she believed that "Junovan" could become a "product platform," with many different applications.